Page last updated: 2024-09-05
biotin and celastrol
biotin has been researched along with celastrol in 1 studies
Compound Research Comparison
| Studies (biotin) | Trials (biotin) | Recent Studies (post-2010) (biotin) | Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) |
|---|---|---|---|---|---|
| 14,847 | 95 | 3,882 | 885 | 1 | 741 |
Protein Interaction Comparison
| Protein | Taxonomy | biotin (IC50) | celastrol (IC50) |
|---|---|---|---|
| Telomerase reverse transcriptase | Homo sapiens (human) | 0.78 | |
| Ubiquitin carboxyl-terminal hydrolase 2 | Homo sapiens (human) | 6.8 | |
| Ubiquitin carboxyl-terminal hydrolase isozyme L1 | Homo sapiens (human) | 6.8 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 8.41 | |
| Ubiquitin carboxyl-terminal hydrolase isozyme L3 | Homo sapiens (human) | 6.8 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 3.45 | |
| Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 3.1 | |
| Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 3.5667 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 0.25 | |
| Regulator of G-protein signaling 17 | Homo sapiens (human) | 6.1795 | |
| Ubiquitin carboxyl-terminal hydrolase 15 | Homo sapiens (human) | 6.8 | |
| Ubiquitin carboxyl-terminal hydrolase isozyme L5 | Homo sapiens (human) | 6.8 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cao, Y; Chen, Y; Cheng, J; Chu, F; Ding, X; Du, S; Durojaye, OA; Gao, X; Li, Y; Liu, X; Shi, X; Song, X; Su, Z; Wang, D; Wang, F; Wang, J; Wang, T; Zeng, W | 1 |
Other Studies
1 other study(ies) available for biotin and celastrol
| Article | Year |
|---|---|
Celastrol inhibits ezrin-mediated migration of hepatocellular carcinoma cells.
Topics: Biotin; Carcinoma, Hepatocellular; Catalytic Domain; Cell Movement; Cytoskeletal Proteins; Disease Progression; HEK293 Cells; Hep G2 Cells; Humans; Liver Neoplasms; Medicine, Chinese Traditional; Molecular Docking Simulation; Neoplasm Invasiveness; Neoplasm Metastasis; Pentacyclic Triterpenes; Phosphorylation; rho-Associated Kinases; Triterpenes; Wound Healing | 2020 |